Finance

Beta
Lists
STZ:NYSE
Constellation Brands Inc
$141.51
+0.23%
(+0.33) 1D
$141.51
0.00% (0.00)
After hours
Closed: Jun 22, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STZ...
Open
$140.29
High
$145.73
Low
$140.29
Mkt. cap
24.27B
Avg. vol.
2.15M
Volume
0.00
Dividend
2.91%
Quarterly dividend
$1.03
Ex-dividend date
Apr 29, 2026
P/E ratio
14.73
52-wk high
$178.14
52-wk low
$126.45
EPS
$9.61
Beta
0.39
Shares outstanding
171.47M
No. of employees
9K
Open
$140.29
High
$145.73
Low
$140.29
Mkt. cap
24.27B
Avg. vol.
2.15M
Volume
0.00
Dividend
2.91%
Quarterly dividend
$1.03
Ex-dividend date
Apr 29, 2026
P/E ratio
14.73
52-wk high
$178.14
52-wk low
$126.45
EPS
$9.61
Beta
0.39
Shares outstanding
171.47M
No. of employees
9K
News stories
From sources across the web
Profile
Constellation Brands, Inc. is an American producer and marketer of beer, wine, and spirits. A Fortune 500 company, Constellation is the largest beer import company in the US, measured by sales, and has the third-largest market share of all major beer suppliers. It also has sizable investments in medical and recreational cannabis through its association with Canopy Growth. Based in Rochester, New York, Constellation has about 40 facilities and approximately 9,000 employees. The company has more than 27 brands in its portfolio. Wine brands include Robert Mondavi, Kim Crawford, Ruffino, and The Prisoner Wine Company. Constellation's beer portfolio includes imported brands such as rights in the United States to Corona, Modelo Especial, Negra Modelo, and Pacífico. Spirits brands include Casa Noble Tequila, High West Whiskey, and Nelson's Green Brier Tennessee Whiskey. Wikipedia
About Constellation Brands Inc
CEONicholas Fink
Employees9.4K
Founded1945
HeadquartersVictor (village), New York, New York, United States
SectorDistillery
Websitecbrands.com
Analyst Ratings
Based on 18 analysts giving stock ratings to STZ in the past 3 months
Buy
Buy
11
Hold
6
Sell
1
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for STZ in the last 3 months.
Highest
Current $141.51
$209.00 (+47.69%)
Average
$177.00 (+25.08%)
Lowest
$152.00 (+7.41%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Peter Grom
UBS
Buy
Reiterated
$175.00
+23.7%
06/17/2026
Peter Galbo
Bank of America Securities
Sell
Reiterated
$152.00
+7.4%
06/12/2026
Nik Modi
RBC Capital
Buy
Maintained
$185.00
+30.7%
06/10/2026
Lauren Lieberman
Barclays
Hold
Maintained
$170.00
+20.1%
06/10/2026
Bonnie Herzog
Goldman Sachs
Buy
Maintained
$180.00
+27.2%
06/03/2026
Michael Lavery
Piper Sandler
Hold
Maintained
$160.00
+13.1%
06/01/2026
Robert Moskow
TD Cowen
Buy
Reiterated
$174.00
+23%
05/28/2026
Nadine Sarwat
Bernstein
Buy
Maintained
$197.00
+39.2%
05/26/2026
Filippo Falorni
Citi
Buy
Reiterated
$185.00
+30.7%
05/15/2026
Robert Ottenstein
Evercore ISI
Buy
Maintained
$175.00
+23.7%
04/15/2026
Christian Junquera
Bank of America Securities
Sell
Maintained
$154.00
+8.8%
04/15/2026
Dara Mohsenian
Morgan Stanley
Hold
Maintained
$183.00
+29.3%
04/15/2026
Gerald Pascarelli
Needham
Buy
Reiterated
$185.00
+30.7%
04/15/2026
Bill Kirk
Roth MKM
Buy
Reiterated
$209.00
+47.7%
04/15/2026
Drew Levine
J.P. Morgan
Hold
Maintained
$168.00
+18.7%
04/13/2026
Kaumil Gajrawala
Jefferies
Hold
Maintained
$158.00
+11.7%
04/13/2026
Stephen Powers
Deutsche Bank
Hold
Maintained
$155.00
+9.5%
04/10/2026
Andrew Strelzik
BMO Capital
Buy
Reiterated
$190.00
+34.3%
04/10/2026
Christopher Carey
Wells Fargo
Buy
Reiterated
$185.00
+30.7%
04/10/2026
Next call in 8 days
Wed, Jul 1, 8:00 AM
Fiscal period
Q1 2027
EPS / Est. (USD)
- / $3.25
Revenue / Est. (USD)
- / 2.40B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
2.52B
2.48B
2.22B
1.92B
Cost of goods sold
1.25B
1.17B
1.04B
964.20M
Cost of revenue
1.25B
1.17B
1.04B
964.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
473.20M
408.60M
430.60M
443.60M
Operating expense
473.20M
408.60M
430.60M
443.60M
Total operating expenses
1.72B
1.58B
1.47B
1.41B
Operating income
794.70M
903.40M
753.90M
512.40M
Other non operating income
-5.50M
-8.30M
-8.10M
-12.10M
EBT including unusual items
611.40M
782.90M
632.30M
351.20M
EBT excluding unusual items
634.70M
805.00M
686.50M
415.40M
Income tax expense
87.60M
296.80M
110.10M
126.50M
Effective tax rate
14.33%
37.91%
17.41%
36.02%
Other operating expenses
-
-
-
-
Net income
516.10M
466.00M
502.80M
201.80M
Net profit margin
20.52%
18.78%
22.62%
10.51%
Earnings per share
3.22
3.63
3.06
1.90
Interest and investment income
1.70M
2.40M
3.80M
2.50M
Interest expense
-100.60M
-89.00M
-86.60M
-85.40M
Net interest expenses
-98.90M
-86.60M
-82.80M
-82.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
899.90M
1.01B
852.90M
625.50M
Gain or loss from assets sale
52.10M
-52.10M
31.90M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer